BTHC III, Inc. (BTHC.OB) Changes Its Name and Stock Symbol to International Stem Cell Corporation (ISCO.OB).OCEANSIDE, Calif. -- BTHC BTHC Boundary Trails Health Centre (Canada) BTHC Bucktail Hunting Club BTHC Braunschweiger Tennis und Hockey Club BTHC Brooke Tower Hall Council BTHC Eugene C. III, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :BTHC) has changed its name and stock symbol to International Stem Cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. Corporation (OTCBB:ISCO ISCO International Standard Classification of Occupations ISCO In-Situ Chemical Oxidation ISCO International Soil Conservation Organization ISCO Information System for Clinical Organisations ). The announcement was made today by Kenneth Aldrich, Chairman of the Board of International Stem Cell Corporation. The name and stock symbol change became effective and the shares commenced trading under its new name and stock symbol "ISCO.OB" with NASDAQ's Over-The-Counter Bulletin Board at market open on January 29, 2007. ABOUT INTERNATIONAL STEM CELL CORPORATION: International Stem Cell is a biotechnology company currently focused on developing therapeutic and research products. In the area of therapeutic product development, ISCO's objective is to create an unlimited source of human cells for use in the treatment of several diseases, including diabetes, liver disease Liver Disease Definition Liver disease is a general term for any damage that reduces the functioning of the liver. Description The liver is a large, solid organ located in the upper right-hand side of the abdomen. and retinal disease through cell transplant therapy. In furtherance of this objective, ISCO is currently developing human stem cells stem cells, unspecialized human or animal cells that can produce mature specialized body cells and at the same time replicate themselves. Embryonic stem cells are derived from a blastocyst (the blastula typical of placental mammals; see embryo), which is very young , techniques to cause those stem cells to be "differentiated" into the specific cell types required for transplant, and manufacturing protocols to produce the cells without contamination with animal by-products Animal by-products are biodegradable wastes consisting of animal carcases, parts of animal carcases, products of animal origin which are not intended for human consumption, includes catering waste (all waste food from restaurants, catering facilities, central kitchens, , a characteristic likely to be important in meeting U.S. Food and Drug Administration requirements. ISCO also provides the specialized cells and growth media needed for therapeutic cell transplantation research to academic and commercial researchers in related fields. For more information, visit the ISCO website at: www.intlstemcell.com. FORWARD-LOOKING STATEMENT forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. This news release contains forward-looking statements relating to the business of ISCO and its subsidiary. Investors are cautioned that such forward-looking statements regarding ISCO, its technology, clinical development and potential applications, constitute forward-looking statements that involve risks and uncertainties, including, without limitation, risks inherent in the development and/or commercialization of potential products, uncertainty in the results of clinical trials or regulatory approvals, need to obtain future capital, and maintenance of intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements. Forward-looking statements in this press release should be evaluated together with the many uncertainties that affect the company's business, particularly those mentioned in the cautionary statements found in the company's Securities and Exchange Commission filings. International Stem Cell Corporation disclaims any intent or obligation to update these forward-looking statements. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion